Evaluation of recurrence score and traditional clinicopathologic assessments in a large ER-positive, lymph node-negative patient cohort.

被引：1
|
作者：
Liebermann, N.
Baehner, F. L.
Soussan-Gutman, L.
Klang, S.
Yoshizawa, C.
Shak, S.
Siegelmann-Danieli, N.
机构：
[1] Clalit Hlth Serv, Tel Aviv, Israel
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Teva Pharmaceut Ind, Netanya, Israel
[4] Genom Hlth, Redwood City, CA USA
[5] Maccabi Hlth Org, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
632
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Using the 21-gene recurrence score and the recently developed Recurrence Score-Clinical-Pathologic to assess recurrence risk in patients with node-negative, ER-positive early-stage breast cancer receiving aromatase inhibitor treatment alone.
    Crager, M.
    Tang, G.
    Shak, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
    Naoi, Yasuto
    Kishi, Kazuki
    Tanei, Tomonori
    Tsunashima, Ryo
    Tominaga, Naoomi
    Baba, Yosuke
    Kim, Seung Jin
    Taguchi, Tetsuya
    Tamaki, Yasuhiro
    Noguchi, Shinzaburo
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (03) : 633 - 641
  • [23] Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
    Yasuto Naoi
    Kazuki Kishi
    Ryo Tsunashima
    Kenzo Shimazu
    Atsushi Shimomura
    Naomi Maruyama
    Masafumi Shimoda
    Naofumi Kagara
    Yosuke Baba
    Seung Jin Kim
    Shinzaburo Noguchi
    Breast Cancer Research and Treatment, 2013, 140 : 299 - 306
  • [24] Expression of Transcription Factors [FOXA1-GATA3] in ER-Positive Node-Negative Breast Cancer.
    Bohn, O. L.
    Carter, G.
    Brusky, A.
    Jankowitz, R.
    Badve, P.
    Chivukula, M.
    MODERN PATHOLOGY, 2011, 24 : 29A - 29A
  • [25] Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
    Yasuto Naoi
    Kazuki Kishi
    Tomonori Tanei
    Ryo Tsunashima
    Naoomi Tominaga
    Yosuke Baba
    Seung Jin Kim
    Tetsuya Taguchi
    Yasuhiro Tamaki
    Shinzaburo Noguchi
    Breast Cancer Research and Treatment, 2011, 128 : 633 - 641
  • [26] 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy
    Mamounas, Eleftherios P.
    Liu, Qing
    Paik, Soonmyung
    Baehner, Frederick L.
    Tang, Gong
    Jeong, Jong-Hyeon
    Kim, S. Rim
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Sing, Amy P.
    Shak, Steven
    Julian, Thomas B.
    Lembersky, Barry C.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Wolmark, Norman
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (04):
  • [27] Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients
    Naoi, Yasuto
    Kishi, Kazuki
    Tsunashima, Ryo
    Shimazu, Kenzo
    Shimomura, Atsushi
    Maruyama, Naomi
    Shimoda, Masafumi
    Kagara, Naofumi
    Baba, Yosuke
    Kim, Seung Jin
    Noguchi, Shinzaburo
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (02) : 299 - 306
  • [28] Development of recurrence risk score using 95-gene classifier and its application to formalin-fixed paraffin-embedded tissues in ER-positive, HER2-negative and node-negative breast cancer
    Naoi, Yasuto
    Saito, Yuria
    Kishi, Kazuki
    Shimoda, Masafumi
    Kagara, Naofumi
    Miyake, Tomohiro
    Tanei, Tomonori
    Shimazu, Kenzo
    Kim, Seung Jin
    Noguchi, Shinzaburo
    ONCOLOGY REPORTS, 2019, 42 (06) : 2680 - 2685
  • [29] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
    Takeo Fujii
    Hiroko Masuda
    Yee Chung Cheng
    Fei Yang
    Aysegul A. Sahin
    Yasuto Naoi
    Yuki Matsunaga
    Akshara Raghavendra
    Arup Kumar Sinha
    Jose Rodrigo Espinosa Fernandez
    Anjali James
    Keisuke Yamagishi
    Tomoko Matsushima
    Robert Schuetz
    Debu Tripathy
    Sachiyo Tada
    Rubie S. Jackson
    Shinzaburo Noguchi
    Seigo Nakamura
    Jared D. Acoba
    Naoto T. Ueno
    Breast Cancer Research and Treatment, 2021, 189 : 455 - 461
  • [30] Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
    Nathan W. D. Lamond
    Chris Skedgel
    Daniel Rayson
    Lynn Lethbridge
    Tallal Younis
    Breast Cancer Research and Treatment, 2012, 133 : 1115 - 1123
12345